Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Perampanel: Does it have broad‐spectrum potential?
Heidrun Potschka, Eugen Trinka
Epilepsia (2018) Vol. 60, Iss. S1, pp. 22-36
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels
Kasper B. Hansen, Lonnie P. Wollmuth, Derek Bowie, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 4, pp. 1469-1658
Open Access | Times Cited: 461
PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice
Vicente Villanueva, Wendyl D’Souza, Hiroko Goji, et al.
Journal of Neurology (2021) Vol. 269, Iss. 4, pp. 1957-1977
Open Access | Times Cited: 52
Efficacy, tolerability and safety of add-on third-generation antiseizure medications in treating focal seizures worldwide: a network meta-analysis of randomised, placebo-controlled trials
Yankun Chen, Wenze Li, Chenfei Lu, et al.
EClinicalMedicine (2024) Vol. 70, pp. 102513-102513
Open Access | Times Cited: 5
Exploring the Evidence for Broad-Spectrum Effectiveness of Perampanel: A Systematic Review of Clinical Data in Generalised Seizures
Eugen Trinka, Simona Lattanzi, Kate Carpenter, et al.
CNS Drugs (2021) Vol. 35, Iss. 8, pp. 821-837
Open Access | Times Cited: 32
The effect of Perampanel on EEG spectral power and connectivity in patients with focal epilepsy
Jacopo Lanzone, Lorenzo Ricci, Mario Tombini, et al.
Clinical Neurophysiology (2021) Vol. 132, Iss. 9, pp. 2176-2183
Closed Access | Times Cited: 29
Diversity of AMPA Receptor Ligands: Chemotypes, Binding Modes, Mechanisms of Action, and Therapeutic Effects
Elena A. Golubeva, Mstislav I. Lavrov, Eugene V. Radchenko, et al.
Biomolecules (2022) Vol. 13, Iss. 1, pp. 56-56
Open Access | Times Cited: 20
Efficacy and tolerability of perampanel in pediatric patients with Dravet syndrome
Shinsaku Yoshitomi, Yukitoshi Takahashi, Tokito Yamaguchi, et al.
Epilepsy Research (2019) Vol. 154, pp. 34-38
Closed Access | Times Cited: 33
Effect of perampanel in reducing depression in patients with focal epilepsy
Mok Yee Ming, Long Chen, Jian Huang, et al.
IBRO Neuroscience Reports (2025) Vol. 18, pp. 257-262
Open Access
Effectiveness and safety of perampanel for pediatric patients with epilepsy: A real‐world study from China
Xiaohui Wang, Taoyun Ji, Maomao Liu, et al.
Pediatric Investigation (2025)
Open Access
A Phase 4, multicenter, prospective, non-interventional, observational study to investigate the effectiveness and safety/tolerability of perampanel when used as first adjunctive therapy in routine clinical practice in people with epilepsy: Study 512
С. Г. Бурд, Giovanni Assenza, Sofia Quintas, et al.
Frontiers in Neurology (2025) Vol. 16
Open Access
The Novel Direct Modulatory Effects of Perampanel, an Antagonist of AMPA Receptors, on Voltage-Gated Sodium and M-type Potassium Currents
Ming-Chi Lai, Ray-Chang Tzeng, Chin‐Wei Huang, et al.
Biomolecules (2019) Vol. 9, Iss. 10, pp. 638-638
Open Access | Times Cited: 27
Efficacy and adverse reactions of perampanel in the treatment of epilepsy in children
Dan Li, Shaoping Huang, Yuqin Wang, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 16
The Network of Tumor Microtubes: An Improperly Reactivated Neural Cell Network With Stemness Feature for Resistance and Recurrence in Gliomas
Xinyue Wang, Jianhao Liang, Haitao Sun
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 15
Perampanel outcomes at different stages of treatment in people with focal and generalized epilepsy treated in clinical practice: Evidence from the PERMIT study
Claudio Liguori, Estevo Santamarina, Adam Strzelczyk, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 9
Gain-of-function and loss-of-function variants in GRIA3 lead to distinct neurodevelopmental phenotypes
Berardo Rinaldi, Allan Bayat, Linda G. Zachariassen, et al.
Brain (2023) Vol. 147, Iss. 5, pp. 1837-1855
Open Access | Times Cited: 9
Intrinsic brain activity differences in perampanel-responsive and non-responsive drug-resistant epilepsy patients: an EEG microstate analysis
Chaofeng Zhu, Juan Li, Dazhu Wei, et al.
Therapeutic Advances in Neurological Disorders (2024) Vol. 17
Open Access | Times Cited: 3
Perampanel for the treatment of epilepsy with genetic aetiology: Real-world evidence from the PERMIT Extension study
Norman Delanty, Rajiv Mohanraj, Rohit Shankar, et al.
Epilepsy Research (2024) Vol. 202, pp. 107339-107339
Open Access | Times Cited: 3
Mode of seizure inhibition by sodium channel blockers, an SV2A ligand, and an AMPA receptor antagonist in a rat amygdala kindling model
Ting Wu, Katsutoshi Ido, Makoto Ohgoh, et al.
Epilepsy Research (2019) Vol. 154, pp. 42-49
Closed Access | Times Cited: 25
Non-competitive AMPA glutamate receptors antagonism by perampanel as a strategy to counteract hippocampal hyper-excitability and cognitive deficits in cerebral amyloidosis
Laura Bellingacci, Martina Tallarico, Andrea Mancini, et al.
Neuropharmacology (2022) Vol. 225, pp. 109373-109373
Closed Access | Times Cited: 12
Risk assessment of arrhythmias related to three antiseizure medications: a systematic review and single-arm meta-analysis
Yu‐Long Li, Shen Su, Mengwen Zhang, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 2
Perampanel reduces paroxysmal depolarizing shift and inhibitory synaptic input in excitatory neurons to inhibit epileptic network oscillations
Ya‐Chin Yang, Guan‐Hsun Wang, Ai‐Yu Chuang, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 22, pp. 5177-5194
Open Access | Times Cited: 18
Effects of perampanel on cognition and quantitative electroencephalography in patients with epilepsy
Seon‐Jae Ahn, Tae‐Joon Kim, Kwang Su, et al.
Epilepsy & Behavior (2020) Vol. 115, pp. 107514-107514
Closed Access | Times Cited: 18
Comparative 12-month retention rate, effectiveness and tolerability of perampanel when used as a first add-on or a late add-on treatment in patients with focal epilepsies: The COM-PER study
Nuno Canas, Catarina Félix, Vanessa Silva, et al.
Seizure (2021) Vol. 86, pp. 109-115
Open Access | Times Cited: 15
The Efficacy and Cognitive Impact of Perampanel Monotherapy in Patients with Self-Limited Epilepsy with Centrotemporal Spikes: A Retrospective Analysis
Yue Xuan, Xiaoming Liu, Jiao Chen, et al.
Neuropsychiatric Disease and Treatment (2023) Vol. Volume 19, pp. 1263-1271
Open Access | Times Cited: 6
Mining and analysis of adverse drug reactions associated with perampanel based on FAERS database
Pengcheng Liu, Yuwei Zhang, Xiaoli Xu, et al.
Epilepsy & Behavior (2023) Vol. 145, pp. 109283-109283
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top